Physician profile
Amarjit D Peter
NPI 1245546894
$2,363.92
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,175 · 2020: $38.09 · 2021: $19.39 · 2022: $60.51 · 2024: $71.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,004.90 | 2019 | |
| Davol INC. | $78.05 | 2019-2020 | |
| Tela Bio, INC. | $73.65 | 2019 | |
| Ethicon US, LLC | $55.19 | 2019-2024 | Echelon Endopath, Vistaseal, Echelon; Endopath |
| Medtronic, INC. | $39.00 | 2024 | Absorbatack |
| Activ Surgical, INC. | $34.51 | 2022 | |
| Depuy Synthes Sales INC. | $26.00 | 2022 | |
| Baudax Bio INC. | $19.39 | 2021 | |
| Integra Lifesciences Corporation | $16.77 | 2019 | |
| Covidien Lp | $12.53 | 2019 | |
| Merit Medical Systems INC | $3.93 | 2024 | Elation Balloon Dilator |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$95,280.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amarjit Peter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.